BU-NOT-SET

CONTACT US
Oral modified release
  • Drug product
Granules
Fact sheet
Semi-solids an overview of current regulatory requirement
  • Drug product
Tube cream
Fact sheet
API relocation strategies for CDMO’s
  • Drug substance
Eyes
Insight
Clinical trial material
  • Drug product
  • Manufacturing
hand scooping pills
Fact sheet
Time and cost-effective solubility improvement
  • Drug substance
Eyes
Insight
Dosage form development trends and technologies
  • Drug product
Eyes
Insight
Vaccine Development and Manufacturing
  • Drug product
  • Manufacturing
Eyes
Insight
Identifying impurities using advanced analytics
  • Analytical chemistry
Eyes
Insight
Recipharm on the impact of COVID-19 on API supply
  • Industry trends
Eyes
Insight
Case study
  • Drug product
  • Manufacturing
Science-led OSD reformulation
Case study
  • Development
  • Drug product
De-risking complex generic OSD development
Insight
  • Development
  • Drug product
Science-led OSD development
White paper
  • Drug product
  • Manufacturing
Advanced deformulation for complex generic development
Webinar
  • Development
  • Drug product
How to turn development challenges into predictable outcomes
Insight
  • Drug product
Managing risk as high-potency manufacturing scales
Insight
  • Drug product
Safely scaling high potency API manufacturing
eBook
  • Development
  • Drug product
A predictive approach to complex OSD development
Video
  • Development
Predictable development for uneventful manufacturing